177 related articles for article (PubMed ID: 11762338)
21. The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis.
Dalm VA; van Hagen PM; Krenning EP
Q J Nucl Med; 2003 Dec; 47(4):270-8. PubMed ID: 14973419
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin receptors in the thymus.
Ferone D; van Hagen PM; Colao A; Annunziato L; Lamberts SW; Hofland LJ
Ann Med; 1999 Oct; 31 Suppl 2():28-33. PubMed ID: 10574152
[TBL] [Abstract][Full Text] [Related]
23. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
24. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin analogs for cancer treatment and diagnosis: an overview.
Scarpignato C; Pelosini I
Chemotherapy; 2001; 47 Suppl 2():1-29. PubMed ID: 11275699
[TBL] [Abstract][Full Text] [Related]
26. How age changes the content of neuroendocrine peptides in the murine gastrointestinal tract.
El-Salhy M; Sandström O
Gerontology; 1999; 45(1):17-22. PubMed ID: 9852376
[TBL] [Abstract][Full Text] [Related]
27. Brain-gut communication: cortistatin, somatostatin and ghrelin.
Broglio F; Papotti M; Muccioli G; Ghigo E
Trends Endocrinol Metab; 2007 Aug; 18(6):246-51. PubMed ID: 17632010
[TBL] [Abstract][Full Text] [Related]
28. Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes.
Ferone D; Pivonello R; Van Hagen PM; Dalm VA; Lichtenauer-Kaligis EG; Waaijers M; Van Koetsveld PM; Mooy DM; Colao A; Minuto F; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1056-66. PubMed ID: 12376335
[TBL] [Abstract][Full Text] [Related]
29. Tumor imaging and therapy using radiolabeled somatostatin analogues.
de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
[TBL] [Abstract][Full Text] [Related]
30. The role of cortistatin in the human immune system.
van Hagen PM; Dalm VA; Staal F; Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):141-7. PubMed ID: 18450367
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer.
Mosca A; Dogliotti L; Berruti A; Lamberts SW; Hofland LJ
Dig Liver Dis; 2004 Feb; 36 Suppl 1():S60-7. PubMed ID: 15077913
[TBL] [Abstract][Full Text] [Related]
32. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine peptide receptors on cells of the immune system.
Garza HH; Carr DJ
Chem Immunol; 1997; 69():132-54. PubMed ID: 9353964
[No Abstract] [Full Text] [Related]
34. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
Ferone D; van Hagen MP; Kwekkeboom DJ; van Koetsveld PM; Mooy DM; Lichtenauer-Kaligis E; Schönbrunn A; Colao A; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
[TBL] [Abstract][Full Text] [Related]
35. A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake.
Kölby L; Bernhardt P; Ahlman H; Wängberg B; Johanson V; Wigander A; Forssell-Aronsson E; Karlsson S; Ahrén B; Stenman G; Nilsson O
Am J Pathol; 2001 Feb; 158(2):745-55. PubMed ID: 11159212
[TBL] [Abstract][Full Text] [Related]
36. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
37. Clinical endocrinology and metabolism. The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders.
Low MJ
Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):607-22. PubMed ID: 15533778
[TBL] [Abstract][Full Text] [Related]
38. Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field.
Dalm VA; Hofland LJ; Lamberts SW
Mol Cell Endocrinol; 2008 May; 286(1-2):262-77. PubMed ID: 17942217
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems.
Scholzen T; Armstrong CA; Bunnett NW; Luger TA; Olerud JE; Ansel JC
Exp Dermatol; 1998; 7(2-3):81-96. PubMed ID: 9583747
[TBL] [Abstract][Full Text] [Related]
40. The neuroendocrine phenotype, cellular plasticity, and the search for genetic switches: redefining the diffuse neuroendocrine system.
Day R; Salzet M
Neuro Endocrinol Lett; 2002; 23(5-6):447-51. PubMed ID: 12500170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
